X4 Pharmaceuticals (XFOR) Stock Price, Quote, News & History | Benzinga

X4 Pharmaceuticals Inc (XFOR) Stock Price, Quote, News & History

XFORNASDAQ

Trade with Public

Trade with Public

$4.16

0.112.72%

At close: Aug 24, 5:00 PM EST

$4.16

0.112.72%

Pre-Market: 4:00 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$4.16

Volume / Avg.

4.00 / 751.78K

Day Range

- - -

52 Wk Range

2.80 - 4.83

Market Cap

$412.45M

P/E Ratio

2.90

Dividend Yield

-

Exchange

NASDAQ

RSI

55

Short Interest

7.38%

Days to Cover

12.75

Recent X4 Pharmaceuticals Inc News

Airsculpt Technologies, Barrick Mining And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

Summary: U.S. stock futures mixed, Dow futures down 0.1%. AirSculpt Technologies shares fell 13.4% after reporting Q2 results in-line with estimates. Other stocks moving lower in pre-market trading include NAMI, BNED, YXT, TENX, MSC, B, VRSK, XFOR, HELP, and SLDB.

Avi Kapoor

Dynavax Technologies, Omeros, Agios Pharmaceuticals, Nike And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Top 3 Health Care Stocks That May Rocket Higher In April

Avi Kapoor

Why Meta Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Avi Kapoor

5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More

Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach.

Shanthi Rexaline

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-83.74M

Investing Cash Flow (TTM)

6.43M

Financing Cash Flow (TTM)

233.07M

Free Cash Flow (TTM)

-88.74M

Capital Expenditure (TTM)

-5.00M

Net Change in Cash (TTM)

155.77M

Analyst Trends and Forecast

1

Mar

1

Jun

1

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$280.22M

PE Ratio (TTM)

2.90

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

26.65

PB Ratio (TTM)

2.64

Earnings Yield % (TTM)

34.50%

Earnings Yield % (FWD)

-17.13%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.57

Company Debt

Total Debt

$76.76M

LT Debt

$76.76M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$195.10M

Debt to Equity

0.50

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$4.16

Volume / Avg.

4.00 / 751.78K

Day Range

- - -

52 Wk Range

2.80 - 4.83

Market Cap

$412.45M

P/E Ratio

2.90

Dividend Yield

-

Exchange

NASDAQ

RSI

55

Short Interest

7.38%

Days to Cover

12.75

About

Sector

Health Care

Industry

Biotechnology

X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine recep...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy X4 Pharmaceuticals (XFOR) stock?

A

You can purchase shares of X4 Pharmaceuticals (NASDAQ:XFOR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are X4 Pharmaceuticals (XFOR) competitors?

A

Other companies in X4 Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for X4 Pharmaceuticals (XFOR) stock?

A

X4 Pharmaceuticals has a consensus price target of $7.88.

Q

What is the current price for X4 Pharmaceuticals (XFOR)?

A

The stock price for X4 Pharmaceuticals (NASDAQ: XFOR) is $4.16 last updated August 25, 2026 at 4:00 PM EDT.

Q

Does X4 Pharmaceuticals (XFOR) pay a dividend?

A

There are no upcoming dividends for X4 Pharmaceuticals.

Q

When is X4 Pharmaceuticals (NASDAQ:XFOR) reporting earnings?

A

X4 Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is X4 Pharmaceuticals (XFOR) going to split?

A

There is no upcoming split for X4 Pharmaceuticals.

Q

What sector and industry does X4 Pharmaceuticals (XFOR) operate in?

A

X4 Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.